Kanamycin, also referred to as kanamycin A, is a prominent aminoglycoside bacteriocidal antibiotic derived from the bacterium Streptomyces kanamycetic. This potent antibacterial agent works effectively in three forms including oral, intravenous, and intramuscular, making it a versatile treatment option for numerous infections. With its primary mechanism targeting the inhibition of protein synthesis in bacteria, kanamycin can effectively impair bacterial growth and proliferation, hence its broad-spectrum activity against both Gram-positive and Gram-negative pathogens. The relevance of kanamycin extends to the treatment of severe bacterial infections like tuberculosis, resistant to certain standard medications.
Parent: Kanamycin
Parent: Kanamycin Sulfate / Kanamycin
The processing and formulation of kanamycin might include inherent impurities and related compounds due to its natural biological derivation and the integral complexities of pharmaceutical manufacturing procedures. These impurities can comprise minute amounts of structurally related aminoglycosides, by-products of the fermentation process, or potential degradation products from storage and handling. However, the detailed concentration of these impurities are notably proprietary information and can vary from product to product, concomitantly, rigorous quality control and standardized analytics promote the adherence to stringent cuts-offs, typically well below the regulatory thresholds, ensuring the safety and efficacy of the antibiotic.
Kanamycin is used to treat a wide array of infections, particularly those instigated by bacteria resistant to other antibiotics. This includes severe infections like tuberculosis.
Kanamycin is used to primarily treat serious bacterial infections including those caused by Gram-positive and Gram-negative pathogens. Moreover, it is used in the medical management of tuberculosis especially in cases that show resistance to standard drugs.
Kanamycin has a bacteriocidal action and operates by inhibiting protein synthesis in bacteria, which in turn prevents their growth and replication.
Yes, kanamycin can be used as a treatment for tuberculosis, specifically drug-resistant tuberculosis.
Yes, kanamycin is a commonly recommended medication for severe cases of tuberculosis, particularly those that are resistant to standard-line drugs.
The dosage of kanamycin depends on several factors like the nature and severity of infection, patient’s age, weight, kidney function among others. Therefore, the exact dosage should be guided by a healthcare professional.
